Related Experiment Video
Updated: Jan 26, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Oligonucleotide-directed STAT3 alternative splicing switch drives anti-tumorigenic outcomes in MCF10 human breast
Vincent Tano1, David A Jans2, Marie A Bogoyevitch1
1Department of Biochemistry and Molecular Biology, Medical Building, University of Melbourne, Parkville, VIC, 3010, Australia.
Abstract:
Signal transducer and activator of transcription 3 (STAT3), a transcription factor responsive to the activation of cytokine receptors, is known for its oncogenic actions. Whilst STAT3α is the predominant spliceform in most tissues, alternative splicing of the STAT3 gene can generate a shorter STAT3β spliceform. Redirecting splicing to enhance STAT3β levels can result in tumor suppression in vivo, and so we evaluated the cellular basis underlying the anti-tumorigenic properties of STAT3β. To investigate the impact of increased STAT3β levels in cancer cells, we implemented a Morpholino-based antisense oligonucleotide strategy to modulate STAT3 spliceform expression in the MCF10CA1h cancer cells of the MCF10 series of human breast cancer cells. We employed nonsense-mediated decay (NMD) oligonucleotides and STAT3α-to-β expression switching (SWI) oligonucleotides to successfully induce STAT3 knockdown and redirect alternative splicing to increase STAT3β levels in MCF10CA1h cells, respectively. Importantly, assessment of the impacts of STAT3 splicing modulation on tumor cell biology showed that the SWI treatment significantly reduced MCF10CA1h cell growth, viability, and migration, whereas NMD treatment was without significant impact, although neither NMD nor SWI oligonucleotides significantly inhibited MCF10CA1h cell invasion through a semi-solid matrix. In conclusion, our data demonstrate that reduced breast cancer cell growth, viability and migration, but not invasion, follow the redirection of STAT3α-to-β expression switching to favour STAT3β expression.
Insights
Enhancing STAT3β spliceform expression in breast cancer cells reduces tumor growth, viability, and migration. This study explores the anti-tumorigenic effects of STAT3β, a shorter spliceform of Signal transducer and activator of transcription 3.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a transcription factor with known oncogenic properties.
- STAT3 exists as predominant STAT3α and shorter STAT3β spliceforms, with STAT3β showing potential tumor suppressive functions.
- Modulating STAT3 alternative splicing to increase STAT3β levels offers a potential anti-cancer strategy.
Purpose of the Study:
- To investigate the cellular mechanisms underlying the anti-tumorigenic effects of the STAT3β spliceform.
- To evaluate the impact of increased STAT3β levels on breast cancer cell biology.
- To assess the efficacy of spliceform-switching strategies in cancer therapy.
Main Methods:
- Utilized Morpholino-based antisense oligonucleotides to modulate STAT3 spliceform expression in MCF10CA1h human breast cancer cells.
- Employed nonsense-mediated decay (NMD) oligonucleotides for STAT3 knockdown and STAT3α-to-β expression switching (SWI) oligonucleotides to increase STAT3β levels.
- Assessed the effects of STAT3 splicing modulation on cancer cell growth, viability, migration, and invasion.
Main Results:
- SWI treatment significantly reduced MCF10CA1h cell growth, viability, and migration.
- NMD treatment showed no significant impact on cancer cell phenotypes.
- Neither NMD nor SWI oligonucleotides significantly inhibited cancer cell invasion through a semi-solid matrix.
Conclusions:
- Redirecting STAT3 alternative splicing to favor STAT3β expression effectively suppresses breast cancer cell growth, viability, and migration.
- STAT3β spliceform plays a crucial role in inhibiting key aspects of tumor progression.
- Targeting STAT3 splicing represents a promising therapeutic avenue for breast cancer, particularly for reducing proliferation and metastasis.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Predicting Reaction Outcomes

